These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 30968813)
1. In utero sFlt-1 exposure differentially affects gene expression patterns in fetal liver. Stojanovska V; Holwerda KM; van der Graaf AM; Verkaik-Schakel RN; Boekschoten MV; Faas MM; Scherjon SA; Plösch T J Dev Orig Health Dis; 2019 Jun; 10(3):353-361. PubMed ID: 30968813 [TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241 [TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
4. Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine. Li SW; Ling Y; Jin S; Lin YF; Chen ZJ; Hu CX; Wang MH; Yao MZ Asian Pac J Trop Med; 2014 Aug; 7(8):663-667. PubMed ID: 25149383 [TBL] [Abstract][Full Text] [Related]
5. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience. Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983 [TBL] [Abstract][Full Text] [Related]
6. Early pregnancy maternal and fetal angiogenic factors and fetal and childhood growth: the Generation R Study. Bergen NE; Bouwland-Both MI; Steegers-Theunissen RP; Hofman A; Russcher H; Lindemans J; Jaddoe VW; Steegers EA Hum Reprod; 2015 Jun; 30(6):1302-13. PubMed ID: 25854264 [TBL] [Abstract][Full Text] [Related]
9. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study. MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567 [TBL] [Abstract][Full Text] [Related]
10. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers? Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726 [TBL] [Abstract][Full Text] [Related]
11. Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction. Shinohara S; Uchida Y; Kasai M; Sunami R Hypertens Pregnancy; 2017 Aug; 36(3):269-275. PubMed ID: 28737473 [TBL] [Abstract][Full Text] [Related]
12. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Vatten LJ; Åsvold BO; Eskild A Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089 [TBL] [Abstract][Full Text] [Related]
13. An sFlt-1:PlGF ratio of 655 is not a reliable cut-off value for predicting perinatal outcomes in women with preeclampsia. Stolz M; Zeisler H; Heinzl F; Binder J; Farr A Pregnancy Hypertens; 2018 Jan; 11():54-60. PubMed ID: 29523274 [TBL] [Abstract][Full Text] [Related]
14. Prenatal smoke effect on mouse offspring Zeng Z; Meyer KF; Lkhagvadorj K; Kooistra W; Reinders-Luinge M; Xu X; Huo X; Song J; Plösch T; Hylkema MN Am J Physiol Lung Cell Mol Physiol; 2020 Mar; 318(3):L549-L561. PubMed ID: 31913647 [TBL] [Abstract][Full Text] [Related]
15. Placental soluble fms-like tyrosine kinase expression in small for gestational age infants and risk for adverse outcomes. Spiel M; Salahuddin S; Pernicone E; Zsengeller Z; Wang A; Modest AM; Karumanchi SA; Hecht JL Placenta; 2017 Apr; 52():10-16. PubMed ID: 28454690 [TBL] [Abstract][Full Text] [Related]
16. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model. Ushida T; Kotani T; Tsuda H; Imai K; Nakano T; Hirako S; Ito Y; Li H; Mano Y; Wang J; Miki R; Yamamoto E; Iwase A; Bando YK; Hirayama M; Ohno K; Toyokuni S; Kikkawa F Free Radic Biol Med; 2016 Dec; 101():524-533. PubMed ID: 27789293 [TBL] [Abstract][Full Text] [Related]
17. A double-hit pre-eclampsia model results in sex-specific growth restriction patterns. Stojanovska V; Dijkstra DJ; Vogtmann R; Gellhaus A; Scherjon SA; Plösch T Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30683649 [TBL] [Abstract][Full Text] [Related]
18. The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes. Chang YS; Chen CN; Jeng SF; Su YN; Chen CY; Chou HC; Tsao PN; Hsieh WS Pediatr Neonatol; 2017 Dec; 58(6):529-533. PubMed ID: 28571908 [TBL] [Abstract][Full Text] [Related]
19. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Tapanainen PJ; Bang P; Wilson K; Unterman TG; Vreman HJ; Rosenfeld RG Pediatr Res; 1994 Aug; 36(2):152-8. PubMed ID: 7526325 [TBL] [Abstract][Full Text] [Related]
20. sFlt-1/PlGF ratio for the prediction of the time of delivery. Graupner O; Lobmaier SM; Ortiz JU; Karge A; Kuschel B Arch Gynecol Obstet; 2018 Sep; 298(3):567-577. PubMed ID: 29968165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]